TY - JOUR
T1 - Clinical significance of phospholipid-dependent anti-ॆ2-glycoprotein I (ॆ2-GPI) antibodies in systemic lupus erythematosus
AU - Kaburaki, J.
AU - Kuwana, M.
AU - Yamamoto, M.
AU - Kawai, S.
AU - Matsuura, E.
AU - Ikeda, Y.
PY - 1995/12
Y1 - 1995/12
N2 - We investigated the clinical significance of IgG phospholipid-dependent anti-ॆ2-glycoprotein I (ॆ2-GPI) antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG phospholipid-dependent anti-ॆ2-GPI antibodies by ELISA. IgG phospholipid-dependent anti-ॆ2-GPI antibodies were detected in 21 of 140 patients (15%) and remained positive from 4 to 98 months. Significantly higher incidences of thrombosis, intrauterine fetal loss, thrombocytopenia, patients with antiphospholipid syndrome (APS), prolonged APTT, BFP-STS and hemolytic anemia were found in SLE patients with phospholipid-dependent anti-ॆ2-GPI antibodies. Moreover, significantly lower incidences of malar rash and serositis were found in SLE patients with phospholipid-dependent anti-ॆ2-GPI antibodies, and the majority of these patients satisfied four or five of the revised criteria items of the American Rheumatism Association. These differences were not observed when we compared clinical manifestations in anticardiolipin antibody-positive patients with those in antibody-negative patients by conventional ELISA. These results indicated that SLE patients with IgG phospholipid-dependent anti-ॆ2-GPI antibodies show an unique form of SLE.
AB - We investigated the clinical significance of IgG phospholipid-dependent anti-ॆ2-glycoprotein I (ॆ2-GPI) antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG phospholipid-dependent anti-ॆ2-GPI antibodies by ELISA. IgG phospholipid-dependent anti-ॆ2-GPI antibodies were detected in 21 of 140 patients (15%) and remained positive from 4 to 98 months. Significantly higher incidences of thrombosis, intrauterine fetal loss, thrombocytopenia, patients with antiphospholipid syndrome (APS), prolonged APTT, BFP-STS and hemolytic anemia were found in SLE patients with phospholipid-dependent anti-ॆ2-GPI antibodies. Moreover, significantly lower incidences of malar rash and serositis were found in SLE patients with phospholipid-dependent anti-ॆ2-GPI antibodies, and the majority of these patients satisfied four or five of the revised criteria items of the American Rheumatism Association. These differences were not observed when we compared clinical manifestations in anticardiolipin antibody-positive patients with those in antibody-negative patients by conventional ELISA. These results indicated that SLE patients with IgG phospholipid-dependent anti-ॆ2-GPI antibodies show an unique form of SLE.
KW - anti-ॆ2-glycoprotein I antibodies
KW - anticardiolipin antibodies
KW - antiphospholipid syndrome
UR - http://www.scopus.com/inward/record.url?scp=0029585359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029585359&partnerID=8YFLogxK
U2 - 10.1177/096120339500400609
DO - 10.1177/096120339500400609
M3 - Article
C2 - 8749570
AN - SCOPUS:0029585359
SN - 0961-2033
VL - 4
SP - 472
EP - 476
JO - Lupus
JF - Lupus
IS - 6
ER -